SV
C
Consumer DefensiveHousehold & Personal ProductsUS

Clorox Co. (CLX) Valuation Assumptions

Review Clorox Co. (CLX) valuation assumptions across intrinsic value, DCF, reverse DCF implied growth, EV/EBITDA, P/FCF, and financial trends.

US · US · USD

Latest price87.11 USD
30D-16.9%
Price vs model medianLimited model referenceModel median is the median base output from applicable absolute models, excluding Reverse DCF.

What price implies

Current price implied expectations

At 87.11 USD, the model implies roughly -2.01% annual FCF growth for 10 years, with required long-term operating margin near Assumption unavailable and terminal growth around 3%. This module is a research reference.

Implied FCF CAGR-2.01%

10-year Reverse DCF scenario

Required long-term operating marginAssumption unavailable

Five-year median × 0.95

Implied terminal growth3%

From current model assumptions

Discount rate assumption8%

Estimated from current sector rules

Adjust assumptions+

Adjust assumptions

Move assumptions to see how the current price implied conditions change.

Forecast horizon10Y

Valuation overview

Stock valuation context

Clorox Co. (CLX) valuation on TickerVal is designed to help readers understand the operating expectations embedded in the current market price. At 87.11 USD, the page brings intrinsic value analysis, DCF outputs, reverse DCF implied growth, EV/EBITDA, P/FCF, and valuation assumptions into one research view within the Consumer Defensive sector and the Household & Personal Products industry. Instead of treating one model as a final answer, TickerVal compares cash-flow, earnings-power, balance-sheet, and relative-multiple lenses so the differences between models are visible. The reverse DCF view currently shows implied growth of -2.0%, while the model median reference sits at a limited composite reference versus the current price. The DCF and reverse DCF sections focus on free cash flow, discount rate, terminal growth, and the long-term growth path implied by the current price. EV/EBITDA and P/FCF provide additional context for capital structure and cash-flow multiples. The financial trends section connects those valuation assumptions back to reported revenue of 7B USD, free cash flow of 780M USD, margins, and balance-sheet facts from public filings. Readers can use the layout to compare assumptions across models before reviewing the underlying source data. This page is intended for transparent research reference, model review, and assumption checking.

Valuation model range vs. current price

Each row shows a model output range, with a vertical line for the current price.

Model output range
DCFCalculated
140.16 USD-222.52 USD
Graham NumberCalculated · Limited reference
19.47 USD-19.47 USD
Owner EarningsCalculated · Limited reference
72.85 USD-156.60 USD
Current price reference line

Why models disagree

Different models rely on different financial facts. The status blocks show which lenses fit this page data.

ModelFitContext
DCFSuitableUseful when recurring free cash flow history exists; sensitive to growth and discount assumptions.
Owner EarningsLimitedLatest owner-earnings proxy is an outlier, so this is a limited scenario reference.
Reverse DCFSuitableShows the FCF growth implied by current price under stated assumptions.
Earnings Power ValueNot meaningfulUseful for mature operating profit, with limited emphasis on growth.
Graham NumberLimitedWorks best when EPS and book value are both positive.
Dividend Discount ModelNot meaningfulNeeds explicit dividend history, which is not included in the current version.
Net-Net Liquidation ValueNot meaningfulRequires current asset and liability detail beyond the current data set.
PEGLimitedA quick growth multiple lens when EPS history is positive.
EV/EBITDANot meaningfulUseful for capital structure context when operating profit is available.
P/FCFLimitedA compact free-cash-flow multiple view for positive FCF years.
P/BLimitedMore useful for asset-heavy balance sheets than asset-light companies.
P/SLimitedA revenue multiple lens when profit or FCF is not stable.
Peer ComparisonNot meaningfulStandardized peer comparisons are not included in the current version.

Model calculation reference

Hover each model row to inspect formulas and inputs.

Current price87.11 USD
Model median referenceLimited model reference
Price vs model medianLimited model reference
Price date2026/05/01
The aggregated models are mostly limited-reference views, so the composite range bar is not shown.
Calculated

DCF

Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.

140.16 USD181.85 USD222.52 USD

-52.1%

181.85 USDCurrent price is 52.1% below the base model value.
Calculated

Owner Earnings

Uses net income, D&A, and capex as an owner-earnings proxy.

72.85 USD119.46 USD156.60 USD
119.46 USDThis model is a limited scenario reference for this sector.Adjusted reference: 325.15 USD
Calculated

Reverse DCF

Solves the forward FCF growth rate implied by the current price.

Implied growth-2.0%

Current price implies roughly -2.0% annualized FCF growth.

-2.0%Current price implies roughly -2.0% annualized FCF growth.
Excluded

Earnings Power Value

Estimates earnings power value without assuming growth.

---
-Operating income data is insufficient.

Updated: 2026/05/03

Key financial trend

Annual financial metrics with switchable views. · Unit: USD

FY2025 · Jun 2025 report14 records
Revenue7B USD
Net income810M USD
Free cash flow780M USD
CapEx220M USD
Operating cash flow981M USD

Valuation basis and non-recurring items

Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.

Expand

A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.

PeriodItemCategoryAfter-tax impactConfidence
2025/06/30Asset impairmentImpairment-352M USDMedium
2025/06/30Restructuring chargesRestructuring-23M USDMedium
2023/06/30Asset impairmentImpairment-260M USDMedium
2023/06/30Restructuring chargesRestructuring-56M USDMedium
Ad placement

Quarterly and annual financial table

Financial DetailsShowing latest 5 / 14
PeriodTypeRevenueNet IncomeAdjusted net incomeFree Cash FlowDiluted EPSAdjusted EPS
2025/06/30Annual7B USD810M USD1B USD780M USD6.529.53
2024/06/30Annual7B USD280M USD-499M USD2.25-
2023/06/30Annual7B USD149M USD465M USD946M USD1.23.74
2022/06/30Annual7B USD462M USD-551M USD3.73-
2021/06/30Annual7B USD710M USD-59M USD945M USD5.58-0.47

Data source and quality

Open to inspect field-level SEC EDGAR source, filing form, and derived notes.

SEC EDGAR

FAQ

Quick notes on price-implied expectations, model differences, and source data.

What is Clorox Co.'s intrinsic value?

Clorox Co.'s intrinsic value on TickerVal is reviewed through DCF outputs, reverse DCF implied growth, EV/EBITDA, P/FCF, valuation assumptions, and financial trends from public filings.

How is CLX valued on TickerVal?

TickerVal values CLX by comparing intrinsic value models, DCF and reverse DCF assumptions, cash-flow multiples, earnings-power references, and reported financial trends.

What does the current stock price imply?

The reverse DCF view estimates the free-cash-flow growth path implied by the current stock price under stated discount-rate and terminal-growth assumptions.

Which valuation models are used?

TickerVal uses DCF, reverse DCF, Owner Earnings, EPV, Graham Number, EV/EBITDA, P/FCF, P/B, P/S, and other model references where the underlying data is available.

Is this investment advice?

No. TickerVal does not provide investment advice, ratings, price targets, or buy/sell recommendations.

Early supporter list

Get notified as TickerVal adds saved assumptions.

Join the research reference list for product updates, model notes, and transparent assumption workflows.

Research reference updates only. Not investment advice.

Ad placement
Research reference note

TickerVal is a research workspace, not a financial advisor. Pages on this site do not provide investment, legal, or tax advice and do not contain buy, sell, hold, ratings, price targets, or personalized recommendations. Financial data is derived from public company filings available through SEC EDGAR. TickerVal independently normalizes and computes valuation assumptions; figures may differ from company reports or other providers. TickerVal is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.